Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anwaar Saeed

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Cancers|October 14, 2023
SLAM Modification as an Immune-Modulatory Therapeutic Approach in CancerAlireza Tojjari, Francis J Giles, Maysa Vilbert, et al.
Journal of Gastrointestinal Cancer|July 20, 2022
Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal MeetingSepideh Gholami, Mustafa Abidalhassan, May Cho, et al.
Cancer Treatment and Research Communications|February 21, 2021
Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinomaRobin Park, Mohammed Al-Jumayli, Kirk Miller, et al.
Frontiers in Bioscience (Landmark Edition)|July 31, 2024
Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy StrategiesAlireza Tojjari, Abdelrahman H Hafez, Ali Saeed, et al.
Expert Opinion on Investigational Drugs|August 5, 2024
Zanzalintinib (XL092): a next-generation tyrosine kinase inhibitor-comprehensive review of early safety & efficacy dataJames Yu, Robin Park, Alireza Tojjari, et al.
Frontiers in Oncology|April 8, 2020
Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-AnalysisRobin Park, Laercio Lopes, Cagney R Cristancho, et al.
Expert Review of Molecular Diagnostics|August 29, 2023
Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?Hassan Abushukair, Obada Ababneh, Ayah Al-Bzour, et al.
Clinical Colorectal Cancer|March 26, 2019
Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced CholangiocarcinomaAnwaar Saeed, Robin Park, Mohammed Al-Jumayli, et al.
Vaccines|August 26, 2023
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular CarcinomaAlireza Tojjari, Ahmed Saeed, Meghana Singh, et al.
Current Issues in Molecular Biology|November 24, 2022
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric CancerAviva Atri-Schuller, Hassan Abushukair, Ludimila Cavalcante, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Cancers|October 14, 2023
SLAM Modification as an Immune-Modulatory Therapeutic Approach in CancerAlireza Tojjari, Francis J Giles, Maysa Vilbert, et al.
Journal of Gastrointestinal Cancer|July 20, 2022
Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal MeetingSepideh Gholami, Mustafa Abidalhassan, May Cho, et al.
Cancer Treatment and Research Communications|February 21, 2021
Exceptional response to Erlotinib monotherapy in EGFR Exon 19-deleted, KRAS wild-type, Chemo-refractory advanced pancreatic adenocarcinomaRobin Park, Mohammed Al-Jumayli, Kirk Miller, et al.
Frontiers in Bioscience (Landmark Edition)|July 31, 2024
Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy StrategiesAlireza Tojjari, Abdelrahman H Hafez, Ali Saeed, et al.
Expert Opinion on Investigational Drugs|August 5, 2024
Zanzalintinib (XL092): a next-generation tyrosine kinase inhibitor-comprehensive review of early safety & efficacy dataJames Yu, Robin Park, Alireza Tojjari, et al.
Frontiers in Oncology|April 8, 2020
Treatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-AnalysisRobin Park, Laercio Lopes, Cagney R Cristancho, et al.
Expert Review of Molecular Diagnostics|August 29, 2023
Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?Hassan Abushukair, Obada Ababneh, Ayah Al-Bzour, et al.
Clinical Colorectal Cancer|March 26, 2019
Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced CholangiocarcinomaAnwaar Saeed, Robin Park, Mohammed Al-Jumayli, et al.
Vaccines|August 26, 2023
A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular CarcinomaAlireza Tojjari, Ahmed Saeed, Meghana Singh, et al.
Current Issues in Molecular Biology|November 24, 2022
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric CancerAviva Atri-Schuller, Hassan Abushukair, Ludimila Cavalcante, et al.
Pageof 17